GlassScriptPhysician profile
Emmeline H Magno
NPI 1457765679
$3,218.00
in general payments reported to CMS, 2019-2025
37 companies · $540 in 2025
The $540 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.80 · 2021: $241 · 2022: $812 · 2023: $780 · 2024: $821 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $458.53 | 2022-2025 | Ofev, Stiolto Respimat |
| Glaxosmithkline, LLC. | $419.25 | 2022-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $309.87 | 2021-2025 | Tezspire, Fasenra, Airsupra |
| Jazz Pharmaceuticals INC. | $283.08 | 2021-2023 | |
| Harmony Biosciences LLC | $212.07 | 2022-2024 | |
| Inari Medical, INC. | $183.25 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $120.39 | 2022-2025 | Glassia |
| Idorsia Pharmaceuticals US INC | $117.39 | 2023 | Quviviq |
| Baxter Healthcare | $92.40 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $87.49 | 2022-2025 | Tezspire |
| Insmed, INC. | $82.76 | 2025 | Brinsupri, Arikayce |
| Pfizer INC. | $79.44 | 2021-2024 | |
| Shionogi INC | $75.29 | 2023-2024 | Fetroja |
| Genzyme Corporation | $72.92 | 2022-2025 | |
| Grifols USA, LLC | $53.23 | 2023-2025 | Prolastin-C Liquid |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $51.18 | 2022-2023 | Hizentra |
| Mylan Specialty L.P. | $47.36 | 2021-2023 | Yupelri |
| United Therapeutics Corporation | $44.63 | 2021-2025 | Tyvaso |
| Avadel Cns Pharmaceuticals, LLC | $34.67 | 2025 | Lumryz |
| Electromed, INC. | $33.43 | 2022-2025 | Smartvest |
| Inspire Medical Systems, INC. | $33.21 | 2023-2024 | Inspire |
| Paratek Pharmaceuticals, INC. | $29.65 | 2022-2024 | Nuzyra |
| Pulmonx Corporation | $29.25 | 2023-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Regeneron Healthcare Solutions, INC. | $26.84 | 2021 | |
| Octapharma USA, INC. | $24.04 | 2024 | Cutaquig |
| Resmed Corp | $23.80 | 2020 | |
| Pharming Healthcare, INC. | $22.78 | 2023 | Ruconest |
| Precigen, INC. | $21.04 | 2025 | |
| Novo Nordisk INC | $20.79 | 2025 | Wegovy |
| Axsome Therapeutics, INC. | $19.28 | 2023 | Sunosi |
| Ceribell, INC. | $19.28 | 2024 | Pocket Eeg Device |
| Philips North America LLC | $18.64 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.90 | 2024 | Horizant |
| Verona Pharma, INC. | $17.56 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $14.07 | 2024 | Eliquis |
| Genentech USA, INC. | $12.99 | 2023 | Xolair |
| Itamar Medical INC | $8.25 | 2024 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmeline Magno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.